Hendrik Van Deventer MD
Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Physician
Join to View Full Profile
101 Manning DrChapel Hill, NC 27514
Phone+1 984-974-0000
Fax+1 984-974-8608
Dr. Van Deventer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 1997 - 2000
University of MichiganResidency, Internal Medicine, 1993 - 1997
Virginia Commonwealth University School of MedicineClass of 1993
Certifications & Licensure
NC State Medical License 1997 - 2025
MI State Medical License 1996 - 2000
American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 44 citationsPhase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.Joshua F. Zeidner, Benjamin G. Vincent, Anastasia Ivanova, Dominic T. Moore, Karen P. McKinnon
Blood Cancer Discovery. 2021-09-10 - 16 citationsSafety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia.Nicholas Tschernia, Vaibhav Kumar, Dominic T. Moore, Benjamin G. Vincent, Catherine C. Coombs
Transplantation and Cellular Therapy. 2021-08-30 - 15 citationsGenomic Characteristics and Prognostic Significance of Co-mutated ASXL1/SRSF2 Acute Myeloid LeukemiaDaniel R. Richardson, David M Swoboda, Dominic T. Moore, Steven M Johnson, Onyee Chan
American Journal of Hematology. 2021-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
